Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies.
Carbohydrates are involved in many immunological responses including the rejection of incompatible blood, tissues and organs. Carbohydrate antigens with Galalpha(1,3)Gal epitopes are recognized by natural antibodies in humans and pose a major barrier for pig-to-human xenotransplantation. Genetically modified pigs have been established that have no functional alpha1,3-galactosyltransferase (alpha1,3GT), which transfers alphaGal to N-acetyllactosamine (LacNAc) type oligosaccharides. However, a low level of Galalpha(1,3)Gal is still expressed in alpha1,3GT knockout animals in the form of a lipid, isoglobotrihexosylceramide (iGb3), which is produced by iGb3 synthase on lactose (Lac) type core structures. Here, we define the reactivity of a series of monoclonal antibodies (mAb) generated in alpha1,3GT-/- mice immunized with rabbit red blood cells (RbRBC), as a rich source of lipid-linked antigens. Interestingly, one mAb (15.101) binds weakly to synthetic and cell surface-expressed Galalpha(1,3)Gal on LacNAc, but strongly to versions of the antigen on Lac cores, including iGb3. Three-dimensional models suggest that the terminal alpha-linked Gal binds tightly into the antibody-binding cavity. Furthermore, antibody interactions were predicted with the second and third monosaccharide units. Collectively, our findings suggest that although the terminal carbohydrate residues confer most of the binding affinity, the fine specificity is determined by subsequent residues in the oligosaccharide.
Milland
Julie
J
Department of Surgery (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia.
Yuriev
Elizabeth
E
Xing
Pei-Xiang
PX
McKenzie
Ian F C
IF
Ramsland
Paul A
PA
Sandrin
Mauro S
MS
D000818:Animals; D000910:Antibodies, Heterophile / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000276:immunology; D000915:Antibody Affinity; D000918:Antibody Specificity / Q000276:immunology*; D000941:Antigens / Q000276:immunology; D001666:Binding Sites, Antibody; D002241:Carbohydrates / Q000276:immunology*; D002460:Cell Line; D004187:Disaccharides / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes / Q000276:immunology*; D006001:Glycoconjugates / Q000276:immunology; D006801:Humans; D006860:Hydrogen Bonding; D051379:Mice; D008958:Models, Molecular; D009844:Oligosaccharides / Q000276:immunology
D000910:Antibodies, Heterophile; D000911:Antibodies, Monoclonal; D000941:Antigens; D002241:Carbohydrates; D004187:Disaccharides; D000939:Epitopes; D006001:Glycoconjugates; D009844:Oligosaccharides; C055075:galactosyl-(1-3)galactose